Oncocyte Corporation (OCX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current OCX market cap is 43.23M. The company's latest EPS is USD -2.1492 and P/E is -1.50.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.6M | -1.33M | 864k | -10.87M | 176k |
| Operating Income | 7.13M | -8.29M | 248k | -22.94M | -9.1M |
| Net Income | 3.03M | -8.33M | -7.23M | -16.2M | -9.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 5.23M | 7.73M | 31.98M | 7.27M |
| Operating Income | -22.52M | -31.26M | -74.48M | -18M | -23.85M |
| Net Income | -22.43M | -29.93M | -64.1M | -73.42M | -28.72M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 82.8M | 87.54M | 81.59M | 74.89M | 70.97M |
| Total Liabilities | 39.34M | 39.22M | 39.1M | 49.3M | 54.05M |
| Total Equity | 37.93M | 43.6M | 37.56M | 20.47M | 11.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 39.86M | 55.42M | 159.56M | 100.09M | 74.89M |
| Total Liabilities | 9.02M | 21.94M | 94.35M | 60.5M | 49.3M |
| Total Equity | 30.84M | 33.48M | 65.22M | 34.29M | 20.47M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.67M | -16.5M | -18.76M | -23.33M | -3.83M |
| Investing | N/A | 123k | -1.17M | -932k | -24k |
| Financing | -28k | 12.25M | 12.22M | 12.19M | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.72M | -25.98M | -35.94M | -45.57M | -23.33M |
| Investing | -12.42M | -11.75M | -13.96M | -4.34M | -932k |
| Financing | 47.87M | 22.8M | 78.75M | 35.81M | 12.19M |
| Market Cap | 43.23M |
| Price to Earnings Ratio | -1.50 |
| Price to Sales Ratio | 5.94 |
| Price to Cash Ratio | 4.58 |
| Price to Book Ratio | 1.69 |
| Dividend Yield | - |
| Shares Outstanding | 13.36M |
| Average Volume (1 week) | 19.07k |
| Average Volume (1 Month) | 70.19k |
| 52 Week Change | -25.97% |
| 52 Week High | 4.64 |
| 52 Week Low | 2.08 |
| Spread (Intraday) | 0.14 (4.13%) |
| Company Name | Oncocyte Corporation |
| Address |
15 cushing irvine, california 92618 |
| Website | https://www.oncocyte.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
